July 1, 2024
Diabetes Articles
July 1, 2024
Guest Editorial
By Aleksandra V. Rachitskaya, MD, FASRS
June 1, 2024
Coding & Reimbursement
By Brandy H. Sperry, COMT, COE, CPC, CPMA
June 1, 2024
Industry Insider
January 1, 2024
AI Comes to Diagnostics
By LOUIS PILLA, CONTRIBUTING EDITOR
July 1, 2023
AI Advances for Diabetic Retinopathy
By KAREN MATAR, MD, YAVUZ CAKIR, MD, Justis P. Ehlers, MD
July 1, 2023
On the Horizon: Diabetic Retinopathy Treatments — Without Injections
By CAROLINE C. AWH, MD, Peter K. Kaiser, MD
July 1, 2023
Guest Editorial
By Arshad M. Khanani, MD, MA, FASRS
July 1, 2023
Industry Insider
By Megan Baldwin, PhD, MAICD
July 1, 2022
APPLICATIONS OF OCTA
By Rishi P. Singh, MD, CHRISTOPHER M. MAATOUK, BA
July 1, 2022
SUPRACHOROIDAL INJECTIONS: XIPERE AND BEYOND
By Mark R. Barakat, MD
July 1, 2022
REACHING BEYOND ANTI-VEGF
By Carl Danzig, MD
July 1, 2022
A SCREENING SUCCESS
By Joseph F. Jalkiewicz, contributing writer
November 1, 2021
25 DEVELOPMENTS AND INNOVATIONS IN 25 YEARS
Advances in diabetic retinopathy surveillance
By Charles C. Wykoff, MD, PhD, Hannah J. Yu, BS
Who should administer anti-VEGF?
By David F. Williams, MD, MBA
Advertisement
Recommendations
Advertisement